12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
During Thursday's after-market session, several health care stocks experienced significant movement. Vaccinex, Bone Biologics, Exagen, Vistagen Therapeutics, RVL Pharmaceuticals, and China Pharma Holding saw increases, while OKYO Pharma, Freeline Therapeutics, SomaLogic, Rallybio, Inhibikase Therapeutics, and YS Biopharma Co experienced decreases.
October 05, 2023 | 9:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bone Biologics stock rose 16.21% to $0.68.
The rise in Bone Biologics' stock price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
China Pharma Holding shares increased by 10.59% to $0.15.
The increase in China Pharma Holding's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
RVL Pharmaceuticals stock increased by 10.62% to $0.12.
The increase in RVL Pharmaceuticals' stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Vaccinex stock increased by 36.5% to $1.12.
The significant increase in Vaccinex's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Vistagen Therapeutics stock increased by 12.49% to $3.51.
The increase in Vistagen Therapeutics' stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Exagen stock increased by 14.97% to $2.38.
The increase in Exagen's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Freeline Therapeutics stock decreased by 8.19% to $3.03.
The decrease in Freeline Therapeutics' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Inhibikase Therapeutics shares fell 6.38% to $0.84.
The decrease in Inhibikase Therapeutics' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
OKYO Pharma stock decreased by 9.6% to $2.27.
The decrease in OKYO Pharma's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Rallybio stock decreased by 6.41% to $3.51.
The decrease in Rallybio's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
SomaLogic stock decreased by 7.51% to $2.09.
The decrease in SomaLogic's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
YS Biopharma Co shares declined by 6.25% to $0.72.
The decrease in YS Biopharma Co's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100